Stockscreener 앱 받기
73.33
8.64%
-7.501
전일 마감가:
$80.83
열려 있는:
$80.83
하루 거래량:
281.66K
Relative Volume:
1.23
시가총액:
$3.37B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.42%
1개월 성능:
-13.27%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$72.01
$86.01
1주일 범위
$69.02
$86.01
52주 변동 폭
$66.00
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Compare BLLN vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
73.58 | 3.70B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
514.80 | 192.62B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
203.43 | 144.77B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
624.80 | 51.65B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
119.50 | 34.09B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
321.78 | 31.30B | 3.17B | 642.63M | 516.49M | 10.77 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-06 | 개시 | Guggenheim | Buy |
| 2025-12-01 | 개시 | BTIG Research | Buy |
| 2025-12-01 | 개시 | JP Morgan | Overweight |
| 2025-12-01 | 개시 | Jefferies | Hold |
| 2025-12-01 | 개시 | Piper Sandler | Overweight |
| 2025-12-01 | 개시 | Stifel | Buy |
| 2025-12-01 | 개시 | Wells Fargo | Equal Weight |
| 2025-12-01 | 개시 | William Blair | Outperform |
모두보기
Billiontoone Inc 주식(BLLN)의 최신 뉴스
Billiontoone's (BLLN) "Buy" Rating Reiterated at Guggenheim - MarketBeat
Billiontoone (NASDAQ:BLLN) Price Target Lowered to $140.00 at BTIG Research - MarketBeat
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge By Investing.com - Investing.com Canada
BillionToOne Swings To Profit In Q4; Lifts FY26 Guidance - Nasdaq
BillionToOne Q4 2025 slides: profitability achieved amid 113% revenue surge - Investing.com South Africa
Billiontoone (NASDAQ:BLLN) Announces Earnings Results - MarketBeat
Billiontoone Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: BillionToOne’s Q4 2025 sees robust growth, stock dips - Investing.com India
BillionToOne (BLLN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
BillionToOne Raises 2026 Guidance, Aligns Incentive Plan - TipRanks
BillionToOne: Q4 Earnings Snapshot - marketscreener.com
(BLLN) BillionToOne Expects 2026 Revenue Range $430M-$445M, vs. FactSet Est of $405.1M - marketscreener.com
Earnings Flash (BLLN) BillionToOne Posts Q4 EPS $0.11, vs. FactSet Est of $0.06 - marketscreener.com
Earnings Flash (BLLN) BillionToOne, Inc. Reports Q4 Revenue $96.1M, vs. FactSet Est of $87.2M - marketscreener.com
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance - GlobeNewswire
Billiontoone (NASDAQ:BLLN) Trading Down 5.7%Time to Sell? - MarketBeat
BillionToOne Stock at $89: Why a New $19.1 Million Position Could Matter Now - AOL.com
BillionToOne: Overview of Fourth Quarter Financial Results - Bitget
Billiontoone (NASDAQ:BLLN) Trading Up 6%Time to Buy? - MarketBeat
BillionToOne Inc expected to post earnings of 8 cents a shareEarnings Preview - TradingView
BillionToOne (BLLN) Launches Two New Add-ons for Northstar Select - Yahoo Finance
InvestingPro’s Fair Value spotted BillionToOne 46% drop in advance By Investing.com - Investing.com UK
BLLN Should I Buy - Intellectia AI
BLLN PE Ratio & Valuation, Is BLLN Overvalued - Intellectia AI
BillionToOne Stock Slumps 13% in February. Analysts Still See $135 Fair Value - TIKR.com
BillionToOne stock sinks 16% ahead of March earnings: what traders are watching - Bez Kabli
Billiontoone (NASDAQ:BLLN) Reaches New 1-Year LowTime to Sell? - MarketBeat
Five new option listings and three option delistings on February 19th - TipRanks
Natera Accuses Worker Who Went to Competitor of Stealing Secrets - Bloomberg Law News
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - The Manila Times
BillionToOne, Inc. Announces Q4 and Full Year 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative
BillionToOne reaffirms FY25 guidance - MSN
BillionToOne, Inc.Class A common stock (Nasdaq:BLLN) Stock Quote - The Chronicle-Journal
Billiontoone, Inc. (NASDAQ:BLLN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
BillionToOne adds pharmacogenomics, clonal filtering to Northstar cancer test - Mugglehead Investment Magazine
BillionToOne expands liquid biopsy platform with two add-on tests By Investing.com - Investing.com Australia
BillionToOne Expands Northstar Platform with Launch of Two New A - GuruFocus
BillionToOne expands liquid biopsy platform with two add-on tests - Investing.com Nigeria
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - Finviz
BillionToOne, Inc. Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select - marketscreener.com
BillionToOne Expands Northstar Platform with Launch of Two New Add-On Liquid Biopsy Applications for Northstar Select® - PR Newswire
BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care - BioSpace
BillionToOne initiated with a Hold at Jefferies - MSN
Billiontoone Inc (BLLN) 재무 분석
Billiontoone Inc (BLLN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.86%
1.97%
자본화:
|
볼륨(24시간):